Thomas A. Luger

43.3k total citations · 6 hit papers
513 papers, 27.5k citations indexed

About

Thomas A. Luger is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Thomas A. Luger has authored 513 papers receiving a total of 27.5k indexed citations (citations by other indexed papers that have themselves been cited), including 260 papers in Dermatology, 152 papers in Immunology and 101 papers in Immunology and Allergy. Recurrent topics in Thomas A. Luger's work include Dermatology and Skin Diseases (188 papers), melanin and skin pigmentation (67 papers) and Allergic Rhinitis and Sensitization (66 papers). Thomas A. Luger is often cited by papers focused on Dermatology and Skin Diseases (188 papers), melanin and skin pigmentation (67 papers) and Allergic Rhinitis and Sensitization (66 papers). Thomas A. Luger collaborates with scholars based in Germany, United States and Austria. Thomas A. Luger's co-authors include Sonja Ständer, Dieter Metze, Markus Böhm, Thomas Schwarz, Thomas Schwarz, Martin Steinhoff, John C. Ansel, Thomas Scholzen, Thomas Brzoska and Stephan Grabbe and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas A. Luger

506 papers receiving 26.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanomedicine—Challenge and Perspectives

2009 1.0k citations Thomas A. Luger et al. profile →
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

2016 650 citations Thomas A. Luger et al. profile →
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

1990 616 citations Thomas Schwarz, John C. Ansel et al. profile →
Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress

2000 615 citations Thomas A. Luger et al. profile →
The microbiome in patients with atopic dermatitis

2018 345 citations Thomas A. Luger et al. profile →
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder

2016 281 citations Thomas A. Luger, Thomas Werfel et al. Journal of Investigative Dermatology profile →

Peers

Countries citing papers authored by Thomas A. Luger

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Luger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Luger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Luger more than expected).

Fields of papers citing papers by Thomas A. Luger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Luger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Luger. The network helps show where Thomas A. Luger may publish in the future.

Co-authorship network of co-authors of Thomas A. Luger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Luger. A scholar is included among the top collaborators of Thomas A. Luger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Luger. Thomas A. Luger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas 2023 ·European Journal of Dermatology ·Thomas A. Luger, Chia‐Yu Chu, (unknown), (unknown), Nikolay N. Murashkin, (unknown), Zuotao Zhao	4
2	Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial 2023 ·Journal of the European Academy of Dermatology and Venereology ·Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaçi, Andreas Pinter, Delphine Kérob, (unknown), Thomas A. Luger	11
3	Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus 2020 ·Pediatric Allergy and Immunology ·Thomas A. Luger, Matthias Augustin, Julien Lambert, C. Paul, Carlo Pincelli, Antonio Torrelo, Christian Vestergaard, Ulrich Wahn, Thomas Werfel	9
4	Haut auf der Grenze zwischen Innen und Außen 2014 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Rudolf Stadler, Roland Kaufmann, Thomas A. Luger	0
5	Galectin-2 Suppresses Contact Allergy by Inducing Apoptosis in Activated CD8+ T Cells 2009 ·The Journal of Immunology ·Karin Loser, Andreas Sturm, Maik Voskort, Verena Kupas, Sandra Balkow, Matteo Auriemma, (unknown), Axel Dignaß, Thomas A. Luger, Stefan Beissert	34
6	A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis 2008 ·Dermatology ·Thomas A. Luger, F. Cambazard, Frederik Grønhøj Larsen, Marc Bourcier, Girish Gupta, (unknown), (unknown), Neil H. Shear	75
7	Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of α-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells 2005 ·Endocrinology ·Markus Böhm, (unknown), Zhuo Li, Stefan W. Schneider, Vinzenz Oji, Sven Diederichs, Gregory S. Barsh, Annika Vogt, Karola Stieler, Ulrike Blume‐Peytavi, Thomas A. Luger	46
8	Antipruritische Therapie mit dem oralen Opiatrezeptor-antagonisten Naltrexon: Offene, nicht placebokontrollierte Anwendung bei 133 patienten 2004 ·Der Hautarzt ·(unknown), Dieter Metze, Thomas A. Luger, Sonja Ständer	5
9	International consensus conference on atopic dermatitis II (ICCAD II) Clinical update & current treatment strategies 2003 ·British Journal of Dermatology ·Charles N. Ellis, Thomas A. Luger	6
10	α-Melanocyte-Stimulating Hormone Inhibits Allergic Airway Inflammation 2003 ·The Journal of Immunology ·Ulrike Raap, Thomas Brzoska, (unknown), G Päth, (unknown), Udo Herz, Armin Braun, Thomas A. Luger, Harald Renz	71
11	Modulation of Cutaneous Inflammation by Angiotensin-Converting Enzyme 2003 ·The Journal of Immunology ·Thomas Scholzen, Sonja Ständer, Helge Riemann, Thomas Brzoska, Thomas A. Luger	70
12	Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals 2002 ·Cell and Tissue Research ·(unknown), (unknown), Hans‐Günther Machens, Thomas Aberle, Walther Burchard, T. Prien, Thomas A. Luger, Dieter Metze	26
13	Keratinocytes in epidermal immune responses 2001 ·Current Opinion in Allergy and Clinical Immunology ·Martin Steinhoff, Thomas Brzoska, Thomas A. Luger	35
14	Neutral Endopeptidase Terminates Substance P-Induced Inflammation in Allergic Contact Dermatitis 2001 ·The Journal of Immunology ·Thomas Scholzen, Martin Steinhoff, Paola Bonaccorsi, Robin Klein, Silvia Amadesi, (unknown), Bao Lu, Norma P. Gerard, John E. Olerud, Thomas A. Luger, Nigel W. Bunnett, Eileen F. Grady, Cheryl A. Armstrong, John C. Ansel	82
15	Mycophenolate Mofetil Impairs the Maturation and Function of Murine Dendritic Cells 2000 ·The Journal of Immunology ·Annette Mehling, Stephan Grabbe, Maik Voskort, Thomas Schwarz, Thomas A. Luger, Stefan Beissert	155
16	Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand 1998 ·Journal of Biological Chemistry ·(unknown), Dagmar Kulms, Birgit Pöppelmann, Thomas A. Luger, Marek Kubin, Thomas Schwarz	92
17	Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment 1997 ·European Journal of Dermatology ·P.C.M. van de Kerkhof, C.J.M. van der Vleuten, M. Gerritsen, Conrad P. Glade, Thomas A. Luger, T. Werfel, (unknown)	17
18	Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. 1995 ·Journal of Clinical Investigation ·Manuel Simon, (unknown), Agatha Schwarz, (unknown), Thomas A. Luger, Marja Jäättelä, Thomas Schwarz	207
19	Detection of the production of interleukin (IL) 12 by human keratinocytes 1994 ·Journal of Investigative Dermatology ·Yoshinori Aragane, Helge Riemann, Ranjit Bhardwaj, Agatha Schwarz, Thomas A. Luger, Marek Kubin, Giorgio Trinchieri, Thomas Schwarz	2
20	[Transient acantholytic dermatosis (Grover) (author's transl)]. 1978 ·PubMed ·Fabian Horn, W. Gebhart, Thomas A. Luger	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact